Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Face | 6 | 2021 | 23 | 3.140 |
Why?
|
Surgery, Plastic | 4 | 2020 | 11 | 2.710 |
Why?
|
Search Engine | 2 | 2021 | 8 | 1.490 |
Why?
|
Nose | 2 | 2020 | 36 | 1.340 |
Why?
|
Rhinoplasty | 3 | 2022 | 14 | 1.050 |
Why?
|
Quality of Life | 2 | 2021 | 659 | 0.990 |
Why?
|
Laryngostenosis | 2 | 2023 | 5 | 0.950 |
Why?
|
Esthetics | 2 | 2020 | 12 | 0.870 |
Why?
|
Photography | 2 | 2020 | 15 | 0.850 |
Why?
|
Skin | 2 | 2020 | 115 | 0.810 |
Why?
|
Narcotics | 2 | 2020 | 37 | 0.800 |
Why?
|
Facial Paralysis | 2 | 2021 | 9 | 0.800 |
Why?
|
Analgesia | 2 | 2020 | 37 | 0.800 |
Why?
|
Information Seeking Behavior | 1 | 2021 | 5 | 0.770 |
Why?
|
Internet | 2 | 2022 | 98 | 0.750 |
Why?
|
Voice | 1 | 2021 | 6 | 0.740 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 151 | 0.740 |
Why?
|
Spirometry | 1 | 2021 | 12 | 0.740 |
Why?
|
Blepharoplasty | 1 | 2021 | 2 | 0.730 |
Why?
|
Cosmetic Techniques | 1 | 2021 | 5 | 0.730 |
Why?
|
Beauty | 1 | 2020 | 2 | 0.700 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2020 | 2 | 0.700 |
Why?
|
Cephalometry | 1 | 2020 | 4 | 0.700 |
Why?
|
Forehead | 1 | 2020 | 3 | 0.690 |
Why?
|
Patients | 1 | 2020 | 35 | 0.680 |
Why?
|
Patient Preference | 1 | 2020 | 33 | 0.680 |
Why?
|
Patient Reported Outcome Measures | 2 | 2021 | 507 | 0.660 |
Why?
|
Humans | 30 | 2023 | 28560 | 0.650 |
Why?
|
Free Tissue Flaps | 1 | 2019 | 14 | 0.650 |
Why?
|
Anesthesia | 1 | 2019 | 31 | 0.650 |
Why?
|
Biomedical Research | 1 | 2020 | 66 | 0.640 |
Why?
|
Social Media | 1 | 2020 | 50 | 0.640 |
Why?
|
Sex Characteristics | 1 | 2020 | 121 | 0.640 |
Why?
|
Pain, Postoperative | 2 | 2020 | 316 | 0.640 |
Why?
|
Health Behavior | 1 | 2020 | 165 | 0.630 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 64 | 0.630 |
Why?
|
Facial Nerve Diseases | 1 | 2018 | 3 | 0.630 |
Why?
|
Endoscopy | 2 | 2019 | 182 | 0.620 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2018 | 4 | 0.620 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2018 | 4 | 0.620 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 196 | 0.620 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 177 | 0.550 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 772 | 0.530 |
Why?
|
Sleep | 1 | 2019 | 356 | 0.520 |
Why?
|
Female | 18 | 2022 | 15818 | 0.460 |
Why?
|
Rhinitis | 3 | 2021 | 143 | 0.440 |
Why?
|
Sinusitis | 3 | 2021 | 161 | 0.430 |
Why?
|
Male | 15 | 2021 | 15400 | 0.390 |
Why?
|
Otolaryngology | 2 | 2021 | 29 | 0.350 |
Why?
|
Middle Aged | 12 | 2021 | 9316 | 0.350 |
Why?
|
Retrospective Studies | 10 | 2020 | 3612 | 0.340 |
Why?
|
Drug Utilization | 2 | 2020 | 22 | 0.340 |
Why?
|
Neoplasm Staging | 3 | 2020 | 371 | 0.320 |
Why?
|
SEER Program | 2 | 2019 | 41 | 0.310 |
Why?
|
Nose Neoplasms | 2 | 2019 | 40 | 0.300 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2019 | 63 | 0.300 |
Why?
|
Aged | 9 | 2021 | 9334 | 0.290 |
Why?
|
Adult | 7 | 2021 | 8168 | 0.280 |
Why?
|
Survival Rate | 4 | 2020 | 356 | 0.260 |
Why?
|
Head | 2 | 2022 | 22 | 0.210 |
Why?
|
Nasal Cartilages | 1 | 2022 | 3 | 0.200 |
Why?
|
Education, Distance | 1 | 2022 | 18 | 0.190 |
Why?
|
Mandibular Nerve | 1 | 2021 | 5 | 0.180 |
Why?
|
Hypoglossal Nerve | 1 | 2021 | 5 | 0.180 |
Why?
|
Speech | 1 | 2021 | 24 | 0.180 |
Why?
|
Nerve Transfer | 1 | 2021 | 5 | 0.180 |
Why?
|
Treatment Outcome | 5 | 2021 | 3620 | 0.180 |
Why?
|
Professional Role | 1 | 2021 | 36 | 0.180 |
Why?
|
Dyspnea | 1 | 2021 | 42 | 0.180 |
Why?
|
Prospective Studies | 3 | 2021 | 1807 | 0.180 |
Why?
|
Glottis | 1 | 2020 | 4 | 0.180 |
Why?
|
Pain Measurement | 2 | 2020 | 472 | 0.170 |
Why?
|
Rejuvenation | 1 | 2020 | 3 | 0.170 |
Why?
|
Prescriptions | 1 | 2020 | 18 | 0.170 |
Why?
|
Biometry | 1 | 2020 | 8 | 0.170 |
Why?
|
Feminization | 1 | 2020 | 2 | 0.170 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2020 | 8 | 0.170 |
Why?
|
Tracheostomy | 1 | 2020 | 27 | 0.170 |
Why?
|
Laryngeal Neoplasms | 1 | 2020 | 32 | 0.170 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 90 | 0.170 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 43 | 0.170 |
Why?
|
Rural Population | 1 | 2020 | 25 | 0.170 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 81 | 0.170 |
Why?
|
Epiglottis | 1 | 2019 | 1 | 0.170 |
Why?
|
Cohort Studies | 3 | 2020 | 1940 | 0.170 |
Why?
|
Tongue | 1 | 2019 | 10 | 0.170 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 935 | 0.170 |
Why?
|
Patient Care Planning | 1 | 2020 | 52 | 0.170 |
Why?
|
Surgeons | 1 | 2021 | 89 | 0.170 |
Why?
|
Simulation Training | 1 | 2020 | 38 | 0.170 |
Why?
|
Motivation | 1 | 2020 | 100 | 0.170 |
Why?
|
Robotic Surgical Procedures | 1 | 2020 | 34 | 0.170 |
Why?
|
Eosinophilia | 1 | 2019 | 37 | 0.160 |
Why?
|
Semicircular Canals | 1 | 2019 | 5 | 0.160 |
Why?
|
Cranial Fossa, Middle | 1 | 2019 | 4 | 0.160 |
Why?
|
Eosinophils | 1 | 2019 | 47 | 0.160 |
Why?
|
Temporal Bone | 1 | 2019 | 8 | 0.160 |
Why?
|
Craniotomy | 1 | 2019 | 21 | 0.160 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2019 | 21 | 0.160 |
Why?
|
Neck | 1 | 2019 | 26 | 0.160 |
Why?
|
Encephalocele | 1 | 2019 | 24 | 0.160 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 134 | 0.160 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 4 | 0.160 |
Why?
|
Betacoronavirus | 1 | 2020 | 77 | 0.160 |
Why?
|
Healthcare Disparities | 1 | 2020 | 85 | 0.160 |
Why?
|
Health Services Accessibility | 1 | 2020 | 110 | 0.160 |
Why?
|
Urban Population | 1 | 2020 | 158 | 0.160 |
Why?
|
Morphine | 1 | 2019 | 61 | 0.160 |
Why?
|
Insurance Coverage | 1 | 2019 | 16 | 0.160 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 35 | 0.150 |
Why?
|
Coronavirus Infections | 1 | 2020 | 90 | 0.150 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 94 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2019 | 147 | 0.150 |
Why?
|
Clinical Competence | 1 | 2020 | 249 | 0.140 |
Why?
|
Registries | 1 | 2018 | 188 | 0.140 |
Why?
|
Internship and Residency | 1 | 2021 | 219 | 0.140 |
Why?
|
Length of Stay | 1 | 2019 | 328 | 0.140 |
Why?
|
Patient Satisfaction | 1 | 2020 | 329 | 0.130 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 216 | 0.130 |
Why?
|
Surveys and Questionnaires | 1 | 2021 | 1220 | 0.120 |
Why?
|
Chronic Disease | 3 | 2021 | 442 | 0.110 |
Why?
|
Young Adult | 1 | 2020 | 2102 | 0.110 |
Why?
|
Prognosis | 3 | 2019 | 826 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 260 | 0.080 |
Why?
|
Illinois | 2 | 2020 | 247 | 0.080 |
Why?
|
United States | 3 | 2019 | 2197 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 307 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2019 | 990 | 0.060 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 33 | 0.050 |
Why?
|
Nasal Septum | 1 | 2022 | 10 | 0.050 |
Why?
|
Nasal Lavage | 1 | 2021 | 4 | 0.050 |
Why?
|
Mometasone Furoate | 1 | 2021 | 8 | 0.050 |
Why?
|
Reading | 1 | 2022 | 42 | 0.050 |
Why?
|
Pituitary-Adrenal System | 1 | 2021 | 13 | 0.050 |
Why?
|
Comprehension | 1 | 2022 | 32 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 23 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2021 | 40 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 31 | 0.050 |
Why?
|
Prevalence | 1 | 2023 | 467 | 0.050 |
Why?
|
Logistic Models | 1 | 2022 | 396 | 0.050 |
Why?
|
Infant | 1 | 2023 | 588 | 0.040 |
Why?
|
Neck Dissection | 1 | 2020 | 20 | 0.040 |
Why?
|
Urbanization | 1 | 2020 | 2 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2020 | 60 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2019 | 66 | 0.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 29 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 81 | 0.040 |
Why?
|
Hearing Loss | 1 | 2019 | 15 | 0.040 |
Why?
|
Neoplasm Grading | 1 | 2019 | 52 | 0.040 |
Why?
|
Patient Selection | 1 | 2020 | 207 | 0.040 |
Why?
|
Databases, Factual | 1 | 2020 | 358 | 0.040 |
Why?
|
Paranasal Sinuses | 1 | 2019 | 62 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 774 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 1194 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2019 | 1863 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 4894 | 0.020 |
Why?
|